Previous 10 | Next 10 |
2023-10-27 16:41:11 ET More on CRISPR Therapeutics, Vertex Pharmaceuticals, etc. Crispr: Upcoming Catalysts, Plenty Of Cash And Strong Partnerships Make It A Buy Vertex Pharmaceuticals Deserves Its Monopoly Premium Indeed CRISPR Therapeutics: CEO Targets $25bn Valuat...
2023-10-27 15:54:52 ET More on bluebird bio bluebird bio And 2seventy bio - Spinner And Spun: The Better Bet In Cell Therapy bluebird bio, Inc. (BLUE) Q2 2023 Earnings Call Transcript HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead Bluebi...
2023-10-26 05:00:00 ET It's a lot easier to convince yourself to buy a stock when it's flying high than when it's in the doldrums. You can see the momentum and imagine it continuing. But when a stock is stagnating or falling -- as long as the company has solid long-term prospects -- those a...
2023-10-25 08:45:00 ET There is no denying that the biotech industry can be pretty risky and volatile, but there are also advantages to investing in stocks in this sector. First, there is always a need for innovative therapies, which is what many biotechs are seeking to develop. Second, pat...
2023-10-24 08:05:14 ET More on Beam, CRISPR, etc. Beam: Opportunity Based On SCD Data Readout In 2024 Crispr: Upcoming Catalysts, Plenty Of Cash And Strong Partnerships Make It A Buy Editas Medicine: A Mispriced Contender In The Gene Editing Arena Beam extend...
2023-10-23 05:30:00 ET Even though the stock market has rallied since the start of the year, with the S&P 500 and the Nasdaq rising by double-digit percentages, some stocks haven't benefited from the positive momentum. And among these stragglers, you might find great deals. Cert...
2023-10-21 05:00:00 ET Cathie Wood's specialty is investing in innovators with potential for explosive growth. The founder of Ark Invest doesn't let short-term stock movements bother her, and she's just fine with waiting for a stock to deliver performance over time. Wood's flagship Ark In...
2023-10-21 03:29:32 ET Summary Cathie Wood and ARK Investment Management have abandoned their "soft landing" theory and are actively preparing for other scenarios. ARK now expects an "economic landing stronger than soft", while facing more than a billion in net fund outflows since...
2023-10-19 03:53:32 ET Summary ARK Invest's 13F portfolio value decreased by 14% to $13.07B this quarter. The top three holdings in the portfolio are Tesla, UiPath, and Coinbase Global. ARK Invest increased its stakes in Block, Twilio, Roblox, Ginkgo Bioworks Holdings, and Rob...
2023-10-16 05:30:00 ET Cathie Wood is known for buying tomorrow's potential success stories today, when their share prices may be in the doldrums and their products haven't yet reached the market -- or haven't reached their full potential. She gets in early at a great price, with the idea o...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website:
2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...